Abstract
Diabetic patients are at increased risk of coronary artery disease, and the choice of revascularization strategy can have important implications on long-term outcomes in these patients. Despite the remarkable results of the FREEDOM trial, controversy still exists regarding whether coronary artery bypass graft (CABG) surgery is superior to percutaneous coronary intervention (PCI) in diabetic patients with multi-vessel coronary artery disease (CAD), particularly in the setting of drug-eluting stents (DES).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
